Add description, images, menus and links to your mega menu
A column with no settings can be used as a spacer
Link to your collections, sales and even external links
Add up to five columns
Add description, images, menus and links to your mega menu
A column with no settings can be used as a spacer
Link to your collections, sales and even external links
Add up to five columns
Maternova curates a portfolio of rapid diagnostic tests (RDTs) and laboratory diagnostics for communicable and infectious diseases that are among the leading causes of maternal and neonatal morbidity and mortality. Our diagnostic solutions support the early detection of conditions such as HIV, syphilis, hepatitis B, hepatitis C, gonorrhea, chlamydia, procalcitonin (infection and sepsis), and neonatal hypothermia.
Many infectious diseases can be transmitted from mother to baby during pregnancy, childbirth, or breastfeeding. Early diagnosis is essential to reduce complications, improve treatment outcomes, and prevent maternal and newborn deaths. Conditions such as syphilis and HIV are particularly important to identify during antenatal and perinatal care.
Our laboratory culture tests are designed as all-in-one cassettes for maximum ease of use in point-of-care (POC) settings, while our rapid diagnostic tests deliver accurate results within minutes without requiring specialized laboratory equipment. Using a small sample of blood, urine, swab, or other specimens, these tests enable healthcare providers to make timely clinical decisions in hospitals, clinics, and community health settings.
Designed specifically for low-resource environments, Maternova's rapid diagnostic solutions are reliable, affordable, and easy to use with minimal training requirements. Products such as the ThermoSpot® infant hypothermia indicator and rapid tests for infectious diseases help frontline healthcare workers quickly identify patients requiring immediate treatment or referral.
Maternova's mission is to make innovative healthcare technologies accessible worldwide. By combining evidence-based diagnostic solutions with end-to-end global procurement and logistics expertise, we help governments, NGOs, hospitals, and healthcare organizations strengthen disease screening programs and improve maternal and newborn health outcomes.
Maternova offers rapid diagnostic tests (RDTs), point-of-care tests, laboratory culture tests, and screening tools for maternal, newborn, and infectious diseases.
Our portfolio includes tests for HIV, syphilis, hepatitis B, hepatitis C, gonorrhea, chlamydia, procalcitonin (infection and sepsis), and neonatal hypothermia.
Yes. Many of our diagnostic products are specifically designed for low-resource and remote healthcare settings where laboratory infrastructure is limited. Most require minimal training and no specialized equipment.
A rapid diagnostic test is a point-of-care test that provides results within minutes using a small patient sample, allowing healthcare providers to make timely treatment and referral decisions.
Yes. Maternova supports bulk procurement and international distribution for governments, NGOs, hospitals, humanitarian organizations, and healthcare programs worldwide.
Product Features Rapid qualitative pregnancy test Detects human chorionic gonadotropin (hCG) Immunochromatographic assay technology Results in approximately 3 minutes Available in dipstick and midstream formats...
Please complete the information below, and someone will contact you.
Simultaneous screening for HIV, Hepatitis B, and Hepatitis C supports earlier diagnosis, faster clinical decision-making, and improved infectious disease management. This rapid test is ideal...
Please complete the information below, and someone will contact you.
Simultaneous screening for HIV and syphilis supports earlier diagnosis, timely treatment, and the prevention of mother-to-child transmission (MTCT). This rapid test enables healthcare professionals to...
Please complete the information below, and someone will contact you.
Product Features Semi-quantitative Procalcitonin (PCT) rapid test Detects human procalcitonin in serum or plasma Point-of-care cassette format Includes reference card for estimating PCT concentration Results...
Please complete the information below, and someone will contact you.
BiliDx Bilirubinometer Jaundice is a significant cause of infant morbidity, particularly in South Asia and Latin America. Many infants are born with too much bilirubin...
Please complete the information below, and someone will contact you.
Rapid HIV screening plays a critical role in early diagnosis, timely treatment, and reducing disease transmission. The Reveal® HIV-1/2 Rapid Test enables healthcare professionals to...
Please complete the information below, and someone will contact you.
Early detection of Neisseria gonorrhoeae infection supports timely treatment, reduces disease transmission, and helps prevent pregnancy-related complications and reproductive health issues. This rapid test enables...
Please complete the information below, and someone will contact you.
Product Features Rapid qualitative detection of Treponema pallidum antibodies Results available in approximately 10 minutes CE-marked rapid diagnostic test Compatible with whole blood, serum, and...
Please complete the information below, and someone will contact you.
Early diagnosis of Chlamydia trachomatis infection is essential to reduce transmission, support timely treatment, and prevent long-term reproductive health complications. This rapid diagnostic test enables...
Please complete the information below, and someone will contact you.
Unlike handheld thermometers that provide only intermittent readings, the Celsi Monitor continuously measures newborn skin temperature every 10 seconds. This enables clinicians to respond immediately...
Please complete the information below, and someone will contact you.
Accurate measurement of postpartum blood loss is essential for the timely recognition and management of postpartum hemorrhage (PPH), one of the leading causes of maternal...
Please complete the information below, and someone will contact you.